Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome

The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of H1V infection, have been known for several years to be limited to individu- als expressing the HLA-B*57:01 gene. Why the ABC hypersensitivity syn- drome is o...

Full description

Saved in:
Bibliographic Details
Published inCell research Vol. 22; no. 12; pp. 1637 - 1639
Main Authors Llano, Anuska, Brander, Christian
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.12.2012
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1001-0602
1748-7838
1748-7838
DOI10.1038/cr.2012.105

Cover

Abstract The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of H1V infection, have been known for several years to be limited to individu- als expressing the HLA-B*57:01 gene. Why the ABC hypersensitivity syn- drome is only seen in HLA-B*57:01- expressing subjects and what the precise mechanisms underlying this intolerance are remain however con- troversial. A series of recent studies, particularly a study by Illing et al. recently published in Nature, now answer some of these questions and offer new opportunities to better understand autoimmune disorders and prevent adverse reactions to other drugs.
AbstractList The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of H1V infection, have been known for several years to be limited to individu- als expressing the HLA-B*57:01 gene. Why the ABC hypersensitivity syn- drome is only seen in HLA-B*57:01- expressing subjects and what the precise mechanisms underlying this intolerance are remain however con- troversial. A series of recent studies, particularly a study by Illing et al. recently published in Nature, now answer some of these questions and offer new opportunities to better understand autoimmune disorders and prevent adverse reactions to other drugs.
The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of HIV infection, have been known for several years to be limited to individuals expressing the HLA-B * 57:01 gene. Why the ABC hypersensitivity syndrome is only seen in HLA-B * 57:01-expressing subjects and what the precise mechanisms underlying this intolerance are remain however controversial. A series of recent studies, particularly a study by Illing et al . recently published in Nature , now answer some of these questions and offer new opportunities to better understand autoimmune disorders and prevent adverse reactions to other drugs.
The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of HIV infection, have been known for several years to be limited to individuals expressing the HLA-B57:01 gene. Why the ABC hypersensitivity syndrome is only seen in HLA-B57:01-expressing subjects and what the precise mechanisms underlying this intolerance are remain however controversial. A series of recent studies, particularly a study by Illing et al. recently published in Nature, now answer some of these questions and offer new opportunities to better understand autoimmune disorders and prevent adverse reactions to other drugs.The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of HIV infection, have been known for several years to be limited to individuals expressing the HLA-B57:01 gene. Why the ABC hypersensitivity syndrome is only seen in HLA-B57:01-expressing subjects and what the precise mechanisms underlying this intolerance are remain however controversial. A series of recent studies, particularly a study by Illing et al. recently published in Nature, now answer some of these questions and offer new opportunities to better understand autoimmune disorders and prevent adverse reactions to other drugs.
The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of HIV infection, have been known for several years to be limited to individuals expressing the HLA-B57:01 gene. Why the ABC hypersensitivity syndrome is only seen in HLA-B57:01-expressing subjects and what the precise mechanisms underlying this intolerance are remain however controversial. A series of recent studies, particularly a study by Illing et al. recently published in Nature, now answer some of these questions and offer new opportunities to better understand autoimmune disorders and prevent adverse reactions to other drugs.
Author Anuska Llano Christian Brander
AuthorAffiliation Irsicaixa AIDS Research Institute- HIVACAT, Hospital Universitari Germans Trias i Pujol, Badalona, Spain Universitat Autonoma de Barcelona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain Institucio Catalana de Reserca i Estudis Avancats (ICREA) Barcelona, Spain
Author_xml – sequence: 1
  givenname: Anuska
  surname: Llano
  fullname: Llano, Anuska
  organization: Irsicaixa AIDS Research Institute – HIVACAT, Hospital Universitari Germans Trias i Pujol
– sequence: 2
  givenname: Christian
  surname: Brander
  fullname: Brander, Christian
  email: cbrander@irsicaixa.es
  organization: Irsicaixa AIDS Research Institute – HIVACAT, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Hospital Universitari Germans Trias i Pujol, Institució Catalana de Reserca i Estudis Avançats (ICREA)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22777424$$D View this record in MEDLINE/PubMed
BookMark eNqNkU1rGzEQhkVJab566r249FJoN5nRx2r3EgihaQspubRnIWtlr8Ku5Ejygv99ZeyEJORQXTTDPPPyzswxOfDBW0I-IJwhsObcxDMKSEsi3pAjlLypZMOagxIDYAU10ENynNIdABVc4DtySKmUklN-RK5_W9Nr79KYZs5PYZhsV4JZ7u3scq6NnlysRts5nUuh36xsTNYnl93k8maWNr6LYbSn5O1CD8m-3_8n5O_19z9XP6ub2x-_ri5vKiNA5ErWNQW5kEZSpLWgjQXdzDuN3bzlVAIFziWTtelayTqDgiNFzmsLFjnjmp2Qi53uaj0vroz1OepBraIbddyooJ16XvGuV8swKSZQSN4WgS97gRju1zZlNbpk7DBob8M6KeR1WRGV7X-gtDwGbQMF_fwCvQvr6MsmthRiS9u2KdTHp-YfXT9cowC4A0wMKUW7UMZlnV3YzuIGhaC2F1cmqu3FSyJKz9cXPQ-yr9PfdnQqlF_a-MToq_invXgf_PK-dDyqc44coGbsH5O2w-Y
CitedBy_id crossref_primary_10_4161_hv_21889
crossref_primary_10_1111_cea_14235
crossref_primary_10_1016_j_immbio_2012_12_001
crossref_primary_10_1111_1348_0421_12769
Cites_doi 10.1097/00130832-200208000-00003
10.1128/JVI.79.16.10218-10225.2005
10.1146/annurev-pharmtox-010611-134701
10.1038/nature11147
10.1097/QAD.0b013e328355fe8f
10.1073/pnas.1207934109
10.1016/j.immuni.2008.04.020
10.1016/j.jaci.2006.03.005
10.1016/j.jaci.2010.11.046
10.1002/eji.201142159
10.1016/j.it.2005.11.001
10.1007/s11882-002-0032-z
10.4049/jimmunol.158.4.1660
10.4049/jimmunol.157.3.1071
10.4049/jimmunol.155.1.462
10.4049/jimmunol.155.5.2670
ContentType Journal Article
Copyright Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 2012
Copyright Nature Publishing Group Dec 2012
Copyright © 2012 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 2012 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
Copyright_xml – notice: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 2012
– notice: Copyright Nature Publishing Group Dec 2012
– notice: Copyright © 2012 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 2012 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
DBID 2RA
92L
CQIGP
W94
WU4
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QO
7QP
7QR
7T5
7TK
7TM
7TO
7U9
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
DOI 10.1038/cr.2012.105
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-自然科学
中文科技期刊数据库-自然科学-生物科学
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database (ProQuest)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE

AIDS and Cancer Research Abstracts
ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central Database Suite (ProQuest)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome
EISSN 1748-7838
EndPage 1639
ExternalDocumentID PMC3515749
2830351751
22777424
10_1038_cr_2012_105
44140063
Genre Journal Article
GroupedDBID ---
-01
-0A
-Q-
-SA
-S~
0R~
29B
2B.
2C.
2RA
2WC
36B
39C
3V.
4.4
406
53G
5GY
5VR
5XA
5XB
5XL
6J9
70F
7X7
88E
8FE
8FH
8FI
8FJ
92E
92I
92L
92M
92Q
93N
9D9
9DA
AADWK
AANZL
AATNV
AAWBL
AAYFA
AAYJO
AAZLF
ABAWZ
ABGIJ
ABJNI
ABUWG
ACAOD
ACBMV
ACBRV
ACBYP
ACGFO
ACGFS
ACIGE
ACIWK
ACKTT
ACPRK
ACRQY
ACTTH
ACVWB
ACZOJ
ADBBV
ADFRT
ADHDB
ADMDM
ADQMX
ADYYL
AEDAW
AEFTE
AEJRE
AENEX
AESKC
AEVLU
AEXYK
AFKRA
AFNRJ
AFRAH
AFSHS
AFUIB
AGEZK
AGGBP
AGHAI
AHMBA
AHSBF
AILAN
AJCLW
AJDOV
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMRJV
AMYLF
AOIJS
AXYYD
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
C1A
CAG
CAJEA
CAJUS
CCEZO
CCPQU
CCVFK
CHBEP
COF
CQIGP
CS3
CW9
DIK
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FA0
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JUIAU
JZLTJ
KQ8
LK8
M1P
M7P
NAO
NQJWS
NXXTH
NYICJ
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
Q--
Q-0
R-A
RNS
RNT
RNTTT
RPM
RT1
S..
SNX
SNYQT
SOHCF
SRMVM
SV3
SWTZT
T8Q
TAOOD
TBHMF
TCJ
TDRGL
TGP
TR2
U1F
U1G
U5A
U5K
UKHRP
W94
WFFXF
WU4
XSB
~88
~WA
AACDK
AAHBH
AASML
AAXDM
AAYZH
ABAKF
ABZZP
ACMJI
AEFQL
AEMSY
AEUYN
AFBBN
AGQEE
AIGIU
ALIPV
FIGPU
LGEZI
LOTEE
NADUK
ROL
SOJ
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7QP
7QR
7T5
7TK
7TM
7TO
7U9
7XB
8FD
8FK
ABRTQ
AZQEC
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c505t-766207f7c72126528e0a8bda1db9427020447376cd973dc154121446e0e1434a3
IEDL.DBID 7X7
ISSN 1001-0602
1748-7838
IngestDate Thu Aug 21 14:02:35 EDT 2025
Thu Sep 04 18:48:11 EDT 2025
Fri Sep 05 12:45:39 EDT 2025
Fri Jul 25 09:02:51 EDT 2025
Wed Feb 19 01:51:42 EST 2025
Thu Apr 24 23:04:00 EDT 2025
Tue Jul 01 03:41:30 EDT 2025
Fri Feb 21 02:38:11 EST 2025
Wed Feb 14 10:43:58 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c505t-766207f7c72126528e0a8bda1db9427020447376cd973dc154121446e0e1434a3
Notes The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of H1V infection, have been known for several years to be limited to individu- als expressing the HLA-B*57:01 gene. Why the ABC hypersensitivity syn- drome is only seen in HLA-B*57:01- expressing subjects and what the precise mechanisms underlying this intolerance are remain however con- troversial. A series of recent studies, particularly a study by Illing et al. recently published in Nature, now answer some of these questions and offer new opportunities to better understand autoimmune disorders and prevent adverse reactions to other drugs.
31-1568/Q
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://www.nature.com/articles/cr2012105.pdf
PMID 22777424
PQID 1221192998
PQPubID 536307
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3515749
proquest_miscellaneous_1464512799
proquest_miscellaneous_1222230980
proquest_journals_1221192998
pubmed_primary_22777424
crossref_citationtrail_10_1038_cr_2012_105
crossref_primary_10_1038_cr_2012_105
springer_journals_10_1038_cr_2012_105
chongqing_primary_44140063
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-12-01
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: 2012-12-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell research
PublicationTitleAbbrev Cell Res
PublicationTitleAlternate Cell Research
PublicationYear 2012
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Chessman, Kostenko, Lethborg (CR5) 2008; 28
Barber, Percival, Arnett, Gumperz, Chen, Parham (CR9) 1997; 158
Adam, Eriksson, Schnyder, Fontana, Pichler, Yerly (CR11) 2012; 42
Bharadwaj, Illing, Theodossis, Purcell, Rossjohn, McCluskey (CR1) 2012; 52
Wu, Sanderson, Farrell (CR4) 2006; 118
Mauri-Hellweg, Zanni, Frei (CR15) 1996; 157
Norcross, Luo, Lu (CR7) 2012; 26
Brander, Mauri-Hellweg, Bettens, Rolli, Goldman, Pichler (CR14) 1995; 155
Pichler (CR2) 2002; 2
Phillips, Chung, Mockenhaupt, Roujeau, Mallal (CR13) 2011; 127
Illing, Vivian, Dudek (CR6) 2012; 486
Ostrov, Grant, Pompeu (CR8) 2012; 109
Mauri-Hellweg, Bettens, Mauri, Brander, Hunziker, Pichler (CR16) 1995; 155
Burrows, Rossjohn, McCluskey (CR12) 2006; 27
Frahm, Adams, Kiepiela (CR10) 2005; 79
Pichler (CR3) 2002; 2
Y Wu (BFcr2012105_CR4) 2006; 118
SR Burrows (BFcr2012105_CR12) 2006; 27
C Brander (BFcr2012105_CR14) 1995; 155
LD Barber (BFcr2012105_CR9) 1997; 158
N Frahm (BFcr2012105_CR10) 2005; 79
PT Illing (BFcr2012105_CR6) 2012; 486
D Mauri-Hellweg (BFcr2012105_CR16) 1995; 155
DA Ostrov (BFcr2012105_CR8) 2012; 109
WJ Pichler (BFcr2012105_CR2) 2002; 2
MA Norcross (BFcr2012105_CR7) 2012; 26
D Mauri-Hellweg (BFcr2012105_CR15) 1996; 157
EJ Phillips (BFcr2012105_CR13) 2011; 127
M Bharadwaj (BFcr2012105_CR1) 2012; 52
D Chessman (BFcr2012105_CR5) 2008; 28
J Adam (BFcr2012105_CR11) 2012; 42
WJ Pichler (BFcr2012105_CR3) 2002; 2
22585534 - Eur J Immunol. 2012 Jul;42(7):1706-16
7602118 - J Immunol. 1995 Jul 1;155(1):462-72
22017685 - Annu Rev Pharmacol Toxicol. 2012;52:401-31
12130944 - Curr Opin Allergy Clin Immunol. 2002 Aug;2(4):301-5
16297661 - Trends Immunol. 2006 Jan;27(1):11-6
21354501 - J Allergy Clin Immunol. 2011 Mar;127(3 Suppl):S60-6
22645359 - Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9959-64
8757611 - J Immunol. 1996 Aug 1;157(3):1071-9
22617051 - AIDS. 2012 Jul 17;26(11):F21-9
11895620 - Curr Allergy Asthma Rep. 2002 Jan;2(1):9-15
16815161 - J Allergy Clin Immunol. 2006 Jul;118(1):233-41
16051815 - J Virol. 2005 Aug;79(16):10218-25
22722860 - Nature. 2012 Jun 28;486(7404):554-8
7650395 - J Immunol. 1995 Sep 1;155(5):2670-8
9029102 - J Immunol. 1997 Feb 15;158(4):1660-9
18549801 - Immunity. 2008 Jun;28(6):822-32
References_xml – volume: 2
  start-page: 301
  year: 2002
  end-page: 305
  ident: CR2
  article-title: Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept
  publication-title: Curr Opin Allergy Clin Immunol
  doi: 10.1097/00130832-200208000-00003
– volume: 79
  start-page: 10218
  year: 2005
  end-page: 10225
  ident: CR10
  article-title: HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load
  publication-title: J Virol
  doi: 10.1128/JVI.79.16.10218-10225.2005
– volume: 52
  start-page: 401
  year: 2012
  end-page: 431
  ident: CR1
  article-title: Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev-pharmtox-010611-134701
– volume: 486
  start-page: 554
  year: 2012
  end-page: 558
  ident: CR6
  article-title: Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
  publication-title: Nature
  doi: 10.1038/nature11147
– volume: 155
  start-page: 2670
  year: 1995
  end-page: 2678
  ident: CR14
  article-title: Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals
  publication-title: J Immunol
– volume: 155
  start-page: 462
  year: 1995
  end-page: 472
  ident: CR16
  article-title: Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine
  publication-title: J Immunol
– volume: 26
  start-page: F21
  year: 2012
  end-page: F29
  ident: CR7
  article-title: Abacavir induces loading of novel self-peptides into HLA-B 57: 01: an autoimmune model for HLA-associated drug hypersensitivity
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328355fe8f
– volume: 109
  start-page: 9959
  year: 2012
  end-page: 9964
  ident: CR8
  article-title: Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1207934109
– volume: 28
  start-page: 822
  year: 2008
  end-page: 832
  ident: CR5
  article-title: Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.04.020
– volume: 158
  start-page: 1660
  year: 1997
  end-page: 1669
  ident: CR9
  article-title: Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity
  publication-title: J Immunol
– volume: 118
  start-page: 233
  year: 2006
  end-page: 241
  ident: CR4
  article-title: Activation of T cells by carbamazepine and carbamazepine metabolites
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2006.03.005
– volume: 127
  start-page: S60
  year: 2011
  end-page: S66
  ident: CR13
  article-title: Drug hypersensitivity: pharmacogenetics and clinical syndromes
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2010.11.046
– volume: 157
  start-page: 1071
  year: 1996
  end-page: 1079
  ident: CR15
  article-title: Cross-reactivity of T cell lines and clones to beta-lactam antibiotics
  publication-title: J Immunol
– volume: 42
  start-page: 1706
  year: 2012
  end-page: 1716
  ident: CR11
  article-title: Avidity determines T-cell reactivity in abacavir hypersensitivity
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201142159
– volume: 27
  start-page: 11
  year: 2006
  end-page: 16
  ident: CR12
  article-title: Have we cut ourselves too short in mapping CTL epitopes?
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2005.11.001
– volume: 2
  start-page: 9
  year: 2002
  end-page: 15
  ident: CR3
  article-title: T cells in drug allergy
  publication-title: Curr Allergy Asthma Rep
  doi: 10.1007/s11882-002-0032-z
– volume: 27
  start-page: 11
  year: 2006
  ident: BFcr2012105_CR12
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2005.11.001
– volume: 158
  start-page: 1660
  year: 1997
  ident: BFcr2012105_CR9
  publication-title: J Immunol
  doi: 10.4049/jimmunol.158.4.1660
– volume: 118
  start-page: 233
  year: 2006
  ident: BFcr2012105_CR4
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2006.03.005
– volume: 42
  start-page: 1706
  year: 2012
  ident: BFcr2012105_CR11
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201142159
– volume: 26
  start-page: F21
  year: 2012
  ident: BFcr2012105_CR7
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328355fe8f
– volume: 109
  start-page: 9959
  year: 2012
  ident: BFcr2012105_CR8
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1207934109
– volume: 79
  start-page: 10218
  year: 2005
  ident: BFcr2012105_CR10
  publication-title: J Virol
  doi: 10.1128/JVI.79.16.10218-10225.2005
– volume: 157
  start-page: 1071
  year: 1996
  ident: BFcr2012105_CR15
  publication-title: J Immunol
  doi: 10.4049/jimmunol.157.3.1071
– volume: 2
  start-page: 9
  year: 2002
  ident: BFcr2012105_CR3
  publication-title: Curr Allergy Asthma Rep
  doi: 10.1007/s11882-002-0032-z
– volume: 486
  start-page: 554
  year: 2012
  ident: BFcr2012105_CR6
  publication-title: Nature
  doi: 10.1038/nature11147
– volume: 52
  start-page: 401
  year: 2012
  ident: BFcr2012105_CR1
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev-pharmtox-010611-134701
– volume: 28
  start-page: 822
  year: 2008
  ident: BFcr2012105_CR5
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.04.020
– volume: 2
  start-page: 301
  year: 2002
  ident: BFcr2012105_CR2
  publication-title: Curr Opin Allergy Clin Immunol
  doi: 10.1097/00130832-200208000-00003
– volume: 155
  start-page: 462
  year: 1995
  ident: BFcr2012105_CR16
  publication-title: J Immunol
  doi: 10.4049/jimmunol.155.1.462
– volume: 127
  start-page: S60
  year: 2011
  ident: BFcr2012105_CR13
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2010.11.046
– volume: 155
  start-page: 2670
  year: 1995
  ident: BFcr2012105_CR14
  publication-title: J Immunol
  doi: 10.4049/jimmunol.155.5.2670
– reference: 18549801 - Immunity. 2008 Jun;28(6):822-32
– reference: 7602118 - J Immunol. 1995 Jul 1;155(1):462-72
– reference: 11895620 - Curr Allergy Asthma Rep. 2002 Jan;2(1):9-15
– reference: 12130944 - Curr Opin Allergy Clin Immunol. 2002 Aug;2(4):301-5
– reference: 16051815 - J Virol. 2005 Aug;79(16):10218-25
– reference: 16815161 - J Allergy Clin Immunol. 2006 Jul;118(1):233-41
– reference: 9029102 - J Immunol. 1997 Feb 15;158(4):1660-9
– reference: 16297661 - Trends Immunol. 2006 Jan;27(1):11-6
– reference: 7650395 - J Immunol. 1995 Sep 1;155(5):2670-8
– reference: 22645359 - Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9959-64
– reference: 8757611 - J Immunol. 1996 Aug 1;157(3):1071-9
– reference: 22585534 - Eur J Immunol. 2012 Jul;42(7):1706-16
– reference: 21354501 - J Allergy Clin Immunol. 2011 Mar;127(3 Suppl):S60-6
– reference: 22017685 - Annu Rev Pharmacol Toxicol. 2012;52:401-31
– reference: 22617051 - AIDS. 2012 Jul 17;26(11):F21-9
– reference: 22722860 - Nature. 2012 Jun 28;486(7404):554-8
SSID ssj0025451
Score 2.0664718
Snippet The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of H1V infection,...
The potentially life-threatening adverse reactions to Abavacir (ABC), a nucleoside analog reverse transcriptase inhibitor for the treatment of HIV infection,...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1637
SubjectTerms 631/250/249/1313
631/80/304
692/700/565/2194
Alleles
Anti-HIV Agents - adverse effects
Anti-HIV Agents - pharmacology
Anti-HIV Agents - therapeutic use
Autoimmune diseases
Autoimmunity - drug effects
Autoimmunity - immunology
Biomedical and Life Sciences
Carbamazepine - pharmacology
Cell Biology
Dideoxynucleosides - adverse effects
Dideoxynucleosides - pharmacology
Dideoxynucleosides - therapeutic use
Drug Hypersensitivity - etiology
Drug Hypersensitivity - genetics
Drug Hypersensitivity - immunology
HIV Infections - drug therapy
HIV Infections - immunology
HIV Infections - metabolism
HLA-B
HLA-B Antigens - genetics
HLA-B Antigens - metabolism
Human immunodeficiency virus
Humans
Hypersensitivity
Life Sciences
Research Highlight
Side effects
Syndrome
不良反应
介导
机制
核苷类似物
综合征
自身免疫性疾病
超敏反应
Title Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome
URI http://lib.cqvip.com/qk/85240X/201212/44140063.html
https://link.springer.com/article/10.1038/cr.2012.105
https://www.ncbi.nlm.nih.gov/pubmed/22777424
https://www.proquest.com/docview/1221192998
https://www.proquest.com/docview/1222230980
https://www.proquest.com/docview/1464512799
https://pubmed.ncbi.nlm.nih.gov/PMC3515749
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEB-0RfBFtH5trWWF-iKEZrPZZPdJqvQogkXEwr0t-TrvoO61t9eC_70z2Y96nvRtlwwhH5PJL5nJbwCOrOezzM5yprgRTDphWSWNYorgq6wC6QlFW5yrswv5ZVpM-wu3tg-rHGxiNNR-6eiO_DgTxEWGxrP8eHXNKGsUeVf7FBoPYTdSl6E-6-ndgQvRQTxwxbAhRZE8e90z8_LYERdoJijNLbEqzJfNz2vcKzZ3py3IuR05-Y_7NO5Kk6fwpIeT6Uk3_8_gQWj24FGXYPL3c5h8DfSyd9H-atNFg5boNnj8SBH1pSfWOHO7WLH4eASBZzrHM-mqpYj2LqVEOtAZvICLyemPz2esz5zAHCKaNdNKCa5n2uH5TqhClIGb0nqTeVtJeoHGpdRoWpyvdO4dwqgsUqcFHhA_SZO_hJ1m2YTXkFqjM8cr7ou8kFbkVrsyeD0LBsGSU2UC--Po1VcdQ0aNGEsS-EngwzCctes5xyn1xWUdfd95WbtVTfOAP0UCR6PwUNF_xQ6Gean79dbWd9qRwLuxGFcKuT9ME5Y3UQaxEK9Kfo8MOXozoasqgVfdVI9tEUIjVhYyAb2hBKMAMXVvljSLeWTszhE1aol1vh_U5a-mb3dx__4uvoHHJNkF1RzAznp1E94iNFrbw6j_h7D76fT82_c_8EsMrw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED6NTgheJhgwMgYEaXtBiuY4jp08IDRgVce2CqFN2luwHZdWYunWdEP7p_gbucsvKEV721uiXK3EvrO_6919B7BtcjYKzSgKJNM8EJabIBVaBpLgq0gd6QllWwzl4FR8PovPVuBXWwtDaZXtnlht1PnU0n_kuyEnLjLcPJP3F5cBdY2i6GrbQqNWi0N38xNdtvLdwSdc3x3O-_snHwdB01UgsHjazwMlJWdqpCz6PlzGPHFMJybXYW5SQdVZTAiFZmfzVEW5RYgRVrRijjnEFkJHOO49WBVU0dqD1Q_7wy9fOxcP8Ujl4lWJSpJyh9brwvZk1xL7aMipsS7xOIynxfdLPJ0Wz8MlkLucq_lPwLY6B_uPYK0BsP5erXGPYcUV63C_bml58wT6x45qiSfleelPCtz7rl2OFz7iTH_PaKuvJ7OgKldBqOuP0QuelZRDXzex8FsChadweiez-gx6xbRwz8E3WoWWpSyPo1gYHhllE5erkdMIz6xMPNjsZi-7qDk5MkR1guCWB2_b6cxsw3JOzTZ-ZFW0PUoyO8toHfAm9mC7E24H-q_YVrsuWWPhZfZHHz140z1G26SAiy7c9KqSQfTF0oTdIkOh5ZCrNPVgo17q7l04V4jOufBALShBJ0Dc4ItPism44giPEKcqgWPutOry16svf-Lm7Z_4Gh4MTo6PsqOD4eELeEi_qlN6tqA3n125lwjM5uZVYw0-fLtrA_wNaPlGBA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9RAEJ8gRsOLQfwqgtYEXkya22633fbBEAJeQJT4IMm91d3t1rtEenA9MPxr_nXObD_wPMMbb206t2l3Z3Z_czPzG4AdXbAy1GUUJEzxQBiug0yoJEgIvorMkp5QtsVpcnQmPo3i0Qr87mphKK2y2xPdRl1MDf1HPgg5cZHh5pkOyjYt4uvhcO_iMqAOUhRp7dppNCpyYm9-oftWfzg-xLXe5Xz48dvBUdB2GAgMnvzzQCYJZ7KUBv0gnsQ8tUylulBhoTNBlVpMCIkmaIpMRoVBuBE6ijHLLOIMoSIc9wE8lBGiKrQlObp19hCZOGfPpSwllEW00ZS4pwNDPKQhpxa7xOgwnlY_LvGcWjwZl-DuctbmP6FbdyIO1-FJC2X9_Ub3nsKKrTbgUdPc8uYZDL9Yqiqe1Oe1P6lwF7y2BV74iDj9fa2Mup7MAle4gqDXH6M_PKspm75pZ-F3VArP4exe5vQFrFbTyr4CXysZGpaxIo5ioXmkpUltIUurEKiZJPVgs5-9_KJh58gR3wkCXh6876YzNy3fObXd-Jm7uHuU5maW0zrgTezBTi_cDfRfsa1uXfLW1uv8VjM9eNc_Riul0Iuq7PTKySAOY1nK7pChIHPIZZZ58LJZ6v5dOJeI07nwQC4oQS9ALOGLT6rJ2LGFR4hYpcAxdzt1-evVlz9x8-5PfAuP0ezyz8enJ69hjX7U5PZswep8dmW3EaHN9RtnCj58v2_b-wMRS0jL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanisms+involved+in+the+Abacavir-mediated+hypersensitivity+syndrome&rft.jtitle=Cell+research&rft.au=Llano%2C+Anuska&rft.au=Brander%2C+Christian&rft.date=2012-12-01&rft.pub=Nature+Publishing+Group&rft.issn=1001-0602&rft.eissn=1748-7838&rft.volume=22&rft.issue=12&rft.spage=1637&rft.epage=1639&rft_id=info:doi/10.1038%2Fcr.2012.105&rft_id=info%3Apmid%2F22777424&rft.externalDocID=PMC3515749
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85240X%2F85240X.jpg